Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New online platform aims to empower doctors and nurses in diabetes care

NCT ID NCT04859205

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether an online training platform called SUPPORT-Pro could increase healthcare professionals' confidence in treating people with type 1 diabetes. The platform provides evidence-based, regularly updated content on topics like medication, diet, and glucose monitoring. 229 healthcare professionals in Canada participated, and their confidence levels were measured before and after using the platform for 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SUPPORT-Pro self-guided online training platform
What this could lead to
If successful, this platform could help healthcare professionals feel more confident in managing type 1 diabetes, potentially improving patient care.
What could go wrong
This is a small, non-randomized study without a control group, so results may not be generalizable. Confidence levels may not translate to better patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

229 people

The number who actually took part.

Started

May 2021

Finished

Feb 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Certified Health Care Professional (nurse, physician (including resident in medicine), dietitian, pharmacist) who is member of a regulatory body in Canada 2. Self-reported working with at least 1 patient with type 1 diabetes in the last six months 3. Has access to the Internet 4. Use of an active email address 5. Comprehension of English or French Exclusion Criteria: 1. Certified diabetes educators 2. Working in a T1D specialized clinic 3. Living with T1D 4. Currently living with someone with T1D (e.g. kid, partner, etc.) 5. Working in the pharmaceutical industry

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Educational activities are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut de Recherches Cliniques de Montréal

    Montreal, Quebec, H2W 1R7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.